M
Medtrum
Medtrum is a diabetes management medical device developer
About Medtrum
Medtrum Technologies, established in Shanghai in 2008 by Yang Cuijun, is a medical device company focused on developing solutions for diabetes management. The company operates in the global diabetes care market, which is experiencing significant growth due to the rising prevalence of the disease. Medtrum's business model involves the development, manufacturing, and sale of its integrated diabetes management systems to patients and healthcare providers. The firm has secured venture capital funding from investors including Sequoia Capital China and BOC Investment to support its manufacturing and research initiatives.
The company's core offering is the TouchCare® system, which integrates a continuous glucose monitor (CGM) and an insulin patch pump, aiming to create a hybrid closed-loop system, sometimes referred to as an 'artificial pancreas'. This system is designed for individuals with Type 1 and Type 2 diabetes who require insulin therapy. Medtrum's product portfolio includes the Nano Patch Pump and the S9 EasySense CGM system. The Nano is a tubeless, waterproof patch pump available in 200U and 300U reservoir sizes, notable for its small and lightweight design. It can be controlled via a dedicated Personal Diabetes Manager (PDM) or a smartphone application, the EasyPatch App, which is compatible with both iOS and Android devices.
The S9 EasySense CGM features a sensor that can be worn for up to 14 days and provides real-time glucose readings every two minutes without requiring finger-prick calibrations. The system includes a slim, rechargeable transmitter that sends data via Bluetooth to a smart device. The accompanying mobile app provides glucose level monitoring, trend analysis, and customizable alerts for high or low glucose events. Data can also be shared remotely with caregivers and healthcare professionals. The integrated TouchCare Nano System uses an algorithm to automatically adjust basal insulin delivery and administer correction boluses based on the CGM readings, helping to increase the user's Time in Range (TIR).
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Huangpu, China
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 47.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Personal Health, Diabetes, Wearable, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Dec 2018 | $29M | $116M | Sequoia · BOCG Investment | — |
| SERIES BEquity / VC | Jan 2018 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Medtrum is 14K monthly website visits, up 55.6% over the last three months. Medtrum's team grew 10% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Sequoia- BIBOCG Investment
Other known investors1 additional known investor
HSG
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medtrum on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medtrum’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





